Excelsa Acquisition Corp.
Status: Stalled
U=S+W/3
W=S@11.5
IPO Proceeds, $M | $250.00M |
---|---|
IPO Date | * |
CEO | Mark Rosen |
Left Lead | Credit Suisse |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
General
Latin America Growth Industries |
IPO Geography | LatAm |
Target Company | TBD |
Deal Announced | TBD |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | TBD |
XLSA
XLSAU
XLSAW
Price | |
---|---|
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Excelsa Acquisition Corp.:
- Structure and cap table
- 8 directors & officers
- 4 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Mark Rosen | 58 | Chief Executive Officer and Director |
Juan Goicochea | 38 | Chief Financial Officer |
Carlos Tomas Rodriguez-Pastor | 61 | Chairman of the Board |
Luis Felipe Castellanos Lopez Torres | 50 | Director |
Juan Pablo del Valle Perochena | 48 | Director |
Martin Migoya | 53 | Director |
Douglas Feagin | 55 | Director |
Antonia Stolper | 63 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Credit Suisse | Joint BR | 12,500,000 | units |
JP Morgan | Joint BR | 12,500,000 | |
25,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 4 filings.